Cancer Cases in India to Rise by 12% by 2025

A 12 % increase in cancer cases will be observed across India in five years as per the National Cancer Registry Program Report 2020.

Cancer cases across the India will increase by 12% in five years as per the National Cancer Registry Program Report 2020, released by the Indian Council of Medical Research and the National Center for Disease Informatics and Research on Tuesday. //

According to the report, India will have 13.9 lakh cancer cases in 2020, which will increase to 15.7 lakh by 2025, based on current trends.

Cervical Cancer Screening Guidelines 2020
American Cancer Society updated the cervical cancer screening guidelines. The new guidelines are simple, and they reflect the developments in cervical cancer prevention.

‘A 12 % increase in cancer cases will be observed across India in five years as per the National Cancer Registry Program Report 2020.’
Read More..

These estimates are based on information related to cancer collected from 28 population-based Cancer Registries and 58 hospital-based Cancer Registries. These results then facilitate efforts to strengthen cancer prevention and control throughout the country.

In 2020, tobacco-related cancers are estimated to contribute 3.7 lakh (27.1 per cent) of the total cancer burden. Among women, breast cancers are estimated to contribute 2 lakh (14.8 per cent) and cervix cancer are estimated to contribute 0.75 lakh (5.4 per cent), whereas for both men and women, cancers of the gastrointestinal tract is estimated to contribute 2.7 lakh (19.7 per cent) of the total cancer burden.

Cancers related to use of any form of tobacco were highest in the northeastern region of the country and in higher proportion in men.

Spironolactone - A Hypertension Diuretic Drug Reduces Prostate Cancer Risk
Spironolactone, a potassium-sparing diuretic drug generally prescribed for hypertension and heart disease, is found to reduce prostate cancer risk.

While cancer of lung, mouth, stomach and esophagus were the most common among men, cancer of breast and cervix uteri were the most common among women.

A significant increase in the incidence rates of breast cancers in women, and lung and head and neck cancers in both men and women was observed in most of the registries, but a declining trend was seen in most of the registries for cancer of the cervix.

Gum Disease Associated With Increased Risk of Esophageal and Gastric Cancer
People with a history of gum disease and tooth loss are at a higher risk of developing esophageal and Gastric Cancer. Bacteria and Oral Hygiene may be the cause

Lung cancer was diagnosed at a stage of spread to distant sites, while cancers of head and neck, stomach, breast and cervix were in higher proportions with locoregional spread.

Multimodality treatment, a varied combination of surgery, chemotherapy and radiation therapy, was administered for cancers of breast and head and neck, while cancer cervix was treated mainly with radiotherapy and chemotherapy. For cancers of the lung and the stomach, systemic therapy was the mode of treatment.

Lethal Delivery of Drugs Using Smart Nanoparticles Brings New Hope to Lung Cancer Patients
Hope for lung cancer patients using a new therapy using smart nanoparticles to deliver high concentration of drugs directly to the blood vessels of the lung tumors killing them.

Source-IANS